HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

One-dose beclomethasone dipropionate aerosol in the treatment of seasonal allergic rhinitis. A preliminary report.

Abstract
Forty-one patients were treated during the birch pollen season for three weeks in a randomized, double-blind placebo controlled preliminary study. Ten patients were treated with beclomethasone dipropionate aerosol 400 micrograms once daily, 10 patients with placebo once daily, 10 patients with 400 micrograms beclomethasone dipropionate in the morning and placebo in the evening and 11 patients with 200 micrograms beclomethasone twice daily. The severity of the nasal symptoms was compared before the trial, during the pollen season without treatment, at the time of peak pollen counts and at the end of the treatment. Symptoms were equally controlled by beclomethasone dipropionate 400 micrograms once daily (two puffs of 100 micrograms per nostril), and 200 micrograms twice daily (two puffs of 50 micrograms per nostril twice). All active drug regimens were better than placebo. In conclusion, this study shows that one-dose beclomethasone dipropionate of 400 micrograms is effective in the treatment of seasonal allergic rhinitis.
AuthorsJ Nuutinen, P Ruoppi, J Suonpää
JournalRhinology (Rhinology) Vol. 25 Issue 2 Pg. 121-7 (Jun 1987) ISSN: 0300-0729 [Print] Netherlands
PMID3303278 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Aerosols
  • Beclomethasone
Topics
  • Adult
  • Aerosols
  • Beclomethasone (administration & dosage)
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Pollen
  • Rhinitis, Allergic, Seasonal (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: